Huntington’s disease affects an estimated 5 to 10 per 100,000 people in most Western countries, with variation by region and ...

Agartala: The Tripura government is set to join hands with the All India Institute of Medical Sciences (AIIMS) Delhi for the ...

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.

Living with TD? Let’s dive into the top five leading therapies for tardive dyskinesia you’ve probably never even heard ...

Videra Health, a leading AI platform for behavioral health providers, has announced the launch of TDScreen, the first-ever automated, video-based AI solution on the market to screen for Tardive ...

Ms. Ryan shared, "I am honored to join the Board of Directors at Westwood Holdings Group,” adding, "I look forward to ...

The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia.

Research from Martin Luther University suggests the asthma drug theophylline helps reduce symptoms in ADCY5-related ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $152.0, a high estimate of $185.00, and a low estimate of $115.00. Highlighting a 1 ...

Rune Labs, which specializes in precision medicine for Parkinson’s disease (PD), has launched of a clinical program with ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...

A recent study conducted by the All India Institute of Medical Sciences (AIIMS), New Delhi, has found that obesity rates ...